36th Annual Meeting
Molecular Biology of Cancer
| Date | Monday, October 22 - Wednesday, October 24, 2007 |
|---|---|
| Location | Gl. Avernæs Conference Centre, Helnæsvej, Ebberup, Fyn |
| Organizers |
Program
Monday, 22 October, 2007: |
|
|
12.00 – 13.00 |
Arrival and Registration. |
|
14.00 – 17.00 |
SESSION I: Epigenetics in cancer. |
|
Organizer: Anders H. Lund, BRIC, Copenhagen University. |
|
|
Anja Groth, Dept. Of Chromatin Dynamics, Institut Curie, France: Epigenetic gene regulation. |
|
|
Karl Agger, Biotech Research and Innovation Centre, Copenhagen University, Denmark: Histone demethylation and cancer. |
|
|
Maarten van Lohuizen, Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands: Polycomb silencers control cell fate, development and cancer. |
|
|
François Fuks, Free University of Brussels, Faculty of Medicine, Laboratory of Molecular Virology, Brussels, Belgium: DNA methylation directed by EZH2. |
|
|
Anders H. Lund, BRIC, Copenhagen University. Polycomb complexes and silencing mechanisms. |
|
|
20.00 – 21.30 |
EMBO LECTURE: Nancy Hynes, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland: ERBB receptors and cancer: the complexity of targeted inhibitors. |
Tuesday, 23 October, 2007: |
|
|
09.00 – 12.00 |
SESSION II: Cellular signaling in cancer. |
|
Organizer: Tuula Kallunki, Danish Cancer Society, Copenhagen. |
|
|
Mark Philips, NYU Cancer Institute, Smilow Research, NYU School of Medicine, New York, USA: Trafficking of small GTPases in relation to cancer. |
|
|
Richard Marais, Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, London, UK: B-Raf mutations in melanoma. |
|
|
Bo Van Deurs, Institute of Medical Anatomy, Copenhagen University, Denmark: Endocytic downregulation of ErbB receptors. |
|
|
Tuula Kallunki, Department of Apoptosis, Institute of Biological Cancer Research, Danish Cancer Society, Copenhagen, Denmark: ErbB2 signaling pathways in the regulation of cysteine cathepsins. |
|
|
Simon Bekker-Jensen, Centre for Genotoxic stress, Danish Cancer Society, Copenhagen, Denmark: DNA damage induces cell cycle arrest via ATR og Chk1 signaling. |
|
|
13.00 – 15.00 |
SESSION III: Young Researchers on Molecular Cancer Biology. |
|
Organizer: Steen Gammeltoft, Glostrup Hospital, Glostrup. |
|
|
Niels Mailand, Centre for Genotoxic stress, Danish Cancer Society, Copenhagen, Denmark: The RNF8 ubiquitin ligase is a novel signalling component in the DNA damage response. |
|
|
Maria Høyer-Hansen, Apoptosis Department, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark: The putative anti-cancer drug, EB1089, induces calcium and CaMKK-β dependent autophagy in breast cancer cells |
|
|
Speakers are selected among submitted abstracts. |
|
|
15.00 – 18.00 |
SESSION IV: Exhibition, Poster Session and Refreshments |
Wednesday, 24 October, 2007: |
|
|
09.00 – 12.00 |
SESSION V: Molecular medicine in cancer management. |
|
Organizer: Peter Hokland, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. |
|
|
Manfred Dietel, Institute of Pathology, Charité, University Hospital Berlin Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. |
|
|
Lars Dyrskøt, Department of Clinical Biochemistry, Skejby Hospital, University of Aarhus, Denmark: Recent developments in molecular profiling of bladder cancer. |
|
|
Bo Sandahl Sørensen, Department of Clinical-Biochemistry, NBG, AS, Aarhus University Hospital, Aarhus, Denmark: Growth factors, chemotherapy and cancer. |
|
|
Jesper Stentoft, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark: Modern therapy of chronic myeloid leukemia: Response evaluation and analysis of failure |
|
|
Peter Hokland, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark: Minimal residual leukemia – a model for translational assays in cancer management. |
|
|
13.00 |
Departure. |